Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tsukada

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 12, 2000
[Pharmacology of conivaptan hydrochloride (YM087), a novel vasopressin V1A/V2 receptor antagonist]T Yatsu, Y Tomura, A Tahara, et al.
Journal of Cardiovascular Pharmacology|January 22, 1998
Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cellsA Tahara, Y Tomura, K Wada, et al.
British Journal of Pharmacology|February 29, 2000
Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cellsA Tahara, J Tsukada, Y Tomura, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1997
Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivoA Tahara, Y Tomura, K I Wada, et al.
British Journal of Pharmacology|June 29, 2001
Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cellsJ Tsukada, A Tahara, Y Tomura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1992
[Adult T-cell leukemia with cervical bone tumor showing immunophenotypic change]N Mori, R Ogawa, A Wake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1992
[Lymphokine-activated killer (LAK) cells and interleukin-2 (IL-2) therapy that improved lymphadenopathy in a patient with B cell non-Hodgkin's lymphoma]K Nakata, R Ogawa, A Wake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1991
[Non-Hodgkin's lymphoma with marked infiltration in calf muscle]N Mori, M Misago, T Hoshuyama, et al.
Blood|July 1, 1992
Interactions between recombinant human erythropoietin and serum factor(s) on murine megakaryocyte colony formationJ Tsukada, M Misago, M Kikuchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1992
[Adult T cell leukemia with cytomegalovirus retinitis]N Mori, K Ura, S Murakami, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 12, 2000
[Pharmacology of conivaptan hydrochloride (YM087), a novel vasopressin V1A/V2 receptor antagonist]T Yatsu, Y Tomura, A Tahara, et al.
Journal of Cardiovascular Pharmacology|January 22, 1998
Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cellsA Tahara, Y Tomura, K Wada, et al.
British Journal of Pharmacology|February 29, 2000
Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cellsA Tahara, J Tsukada, Y Tomura, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1997
Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivoA Tahara, Y Tomura, K I Wada, et al.
British Journal of Pharmacology|June 29, 2001
Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cellsJ Tsukada, A Tahara, Y Tomura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1992
[Adult T-cell leukemia with cervical bone tumor showing immunophenotypic change]N Mori, R Ogawa, A Wake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1992
[Lymphokine-activated killer (LAK) cells and interleukin-2 (IL-2) therapy that improved lymphadenopathy in a patient with B cell non-Hodgkin's lymphoma]K Nakata, R Ogawa, A Wake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1991
[Non-Hodgkin's lymphoma with marked infiltration in calf muscle]N Mori, M Misago, T Hoshuyama, et al.
Blood|July 1, 1992
Interactions between recombinant human erythropoietin and serum factor(s) on murine megakaryocyte colony formationJ Tsukada, M Misago, M Kikuchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1992
[Adult T cell leukemia with cytomegalovirus retinitis]N Mori, K Ura, S Murakami, et al.
Pageof 6